Ailawadhi, S. Et Al. 2024. Iopofosine I 131 in Previously Treated Patients with Waldenstrom Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM). 66th ASH Annual Meeting .

Ailawadhi, S., Gavriatopoulou, M., Peterson, J., Ntanasis-Stathopoulos, I., El-Haddad, G., Grajales-Cruz, A., ... CENGİZ SEVAL, G.(2024). Iopofosine I 131 in Previously Treated Patients with Waldenstrom Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM) . 66th ASH Annual Meeting

Ailawadhi, Sikander Et Al. "Iopofosine I 131 in Previously Treated Patients with Waldenstrom Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM)," 66th ASH Annual Meeting, 2024

Ailawadhi, Sikander Et Al. "Iopofosine I 131 in Previously Treated Patients with Waldenstrom Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM)." 66th ASH Annual Meeting , 2024

Ailawadhi, S. Et Al. (2024) . "Iopofosine I 131 in Previously Treated Patients with Waldenstrom Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM)." 66th ASH Annual Meeting .

@conferencepaper{conferencepaper, author={Sikander Ailawadhi Et Al. }, title={Iopofosine I 131 in Previously Treated Patients with Waldenstrom Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM)}, congress name={66th ASH Annual Meeting}, city={}, country={}, year={2024}}